Loading…

Positive effect of peptide‐calcium chelates from Grifola frondosa on a mouse model of senile osteoporosis

Calcium supplementation has been shown to be efficacious in mitigating the progression of senile osteoporosis (SOP) and reducing the incidence of osteoporotic fractures resulting from prolonged calcium shortage. In this study, Grifola frondosa (GF) peptides‐calcium chelate were synthesized through t...

Full description

Saved in:
Bibliographic Details
Published in:Journal of food science 2024-06, Vol.89 (6), p.3816-3828
Main Authors: Xiong, Yu, Li, Jing‐Ru, Peng, Pei‐Zhi, Liu, Bin, Zhao, Li‐Na
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Calcium supplementation has been shown to be efficacious in mitigating the progression of senile osteoporosis (SOP) and reducing the incidence of osteoporotic fractures resulting from prolonged calcium shortage. In this study, Grifola frondosa (GF) peptides‐calcium chelate were synthesized through the interaction between peptide from GF and CaCl2. The chelation reaction was shown to involve the participation of the amino and carboxyl groups in the peptide, as revealed by scanning electron microscope, Fourier‐transform infrared, and ultraviolet spectrophotometry. Furthermore, a mouse model of (SOP) induced by d‐galactose was established (SCXK‐2018‐0004). Results demonstrated that low dosage of low‐molecular weight GF peptides‐calcium chelates (LLgps‐Ca) could significantly improve serum index and pathological features of bone tissue and reduce bone injury. Further research suggested that LLgps‐Ca could ameliorate SOP by modulating the disrupted metabolic pathway, which includes focal adhesion, extracellular matrix receptor interaction, and PI3K‐Akt signaling pathway. Using Western blot, the differentially expressed proteins were further confirmed. Thus, calciumchelating peptides from GF could serve as functional calcium agents to alleviate SOP.
ISSN:0022-1147
1750-3841
1750-3841
DOI:10.1111/1750-3841.17073